Basic Information
| ID | DRAMP21130 |
|---|
| Sequence | RRWHRWWRR |
|---|
| Length | 9 |
|---|
| Name | P2 (Derived from P5) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram- |
|---|
| Pathogen | [Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=5.2 μM, MBC=32 μM), Staphylococcus aureus(MIC=25.6 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=14.4 μM, MBC>128 μM) |
|---|
| Hemolytic Activity | [Ref.28372989] MHC5>86.67 μM against human red blood cells |
|---|
| Cytotoxicity | [Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 99.6%, 98%, 95.6%, 98.8% and 90.4% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM. |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Amidation |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 28372989 |
|---|
